Home Care in Allogeneic Haematopoietic Stem Cell Transplantation
NCT ID: NCT04707417
Last Updated: 2023-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
16 participants
OBSERVATIONAL
2022-02-01
2023-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Standardized Nursing Intervention Protocol for HCT Patients
NCT00951626
A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation
NCT03667599
Prevention of GVHD in Patients Treated With Allogeneic SCT: Possible Role of Extracorporeal Photophoresis
NCT03204721
Late Effects and HRQoL in Survivors of Allo-HSCT - a Cross Sectional Study
NCT06277479
Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2
NCT02218151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are qualitative and quantitative aspects to the study. The qualitative part involves focus groups interviews with patients that have been treated with allo-HSCT and have recieved home care and their caregivers.
In the prospective observational cohort study data will be collected to compare patients receiving home care and patients treated in-hospital (control group). Patients in both groups wil answer the questionnaire EORTC QLQ-C30 once weekly for 6 weeks. In addition transplant- and treatment-specific variables will be collected and compares between the groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home care
Advanced home care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18
* Understanding and willing to comply with written and oral instructions in Norwegian
* Planned treatment with allo-HSCT
* ECOG performance status 0-2
* Caregiver (age ≥18) present 24 hours a day during the aplastic phase
* Travelling distance from residence to the hospital must be less than one hour.
* Uncontrolled infection or other medical condtion unsuitable for out patient care
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anders E. L. Myhre
Consultant Haematologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Haematology, Division of Cancer Medicine, Oslo University Hospital
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
212733
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.